Clinical Trials Sponsored by Seventh People's Hospital of Hangzhou

Total 2801 results

First People's Hospital of Hangzhou
Hangzhou Cancer Hospital

Recruiting

Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer

Non Small Cell Lung Cancer | Brain Metastases | Stage IV Non-small Cell Lung Cancer

China
First People's Hospital of Hangzhou
Hangzhou Cancer Hospital

Recruiting

A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC

Non Small Cell Lung Cancer | EGFR Activating Mutation | Stage III NSCLC

China
First People's Hospital of Hangzhou

Recruiting

Cangpo Liujun Prescription on Cancer-related Fatigue in Advanced Colorectal Cancer With Spleen Deficiency and Dampness Excess

Colorectal Cancer | Cancer-Related Fatigue

China
First People's Hospital of Hangzhou

Recruiting

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

Chronic Hepatitis b | Tenofovir Alafenamide Fumarate

China
First People's Hospital of Hangzhou

Not yet recruiting

The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies

Biliary Tract Cancer | Gemcitabine | Immune Checkpoint Inhibitors

China
First People's Hospital of Hangzhou

Not yet recruiting

Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation

Colon Disease
First People's Hospital of Hangzhou

Recruiting

A Single-arm, Phase Ⅱ Clinical Trial of Anlotinib Hydrochloride Combined With Irinotecan or Docetaxel for Second Line Treatment of Nonsensitive Relapsed Small-cell Lung Cancer

Relapsed Small Cell Lung Cancer | Anlotinib

China
First People's Hospital of Hangzhou

Recruiting

A Non-invasive Index of Microciculatory Resistance

Coronary Artery Disease | Coronary Microvascular Disease

China
First People's Hospital of Hangzhou

Completed

SpyGlass Versus ESWL for Large Common Bile Duct Stones

Choledocholithiasis | Common Bile Duct Calculi

China
First People's Hospital of Hangzhou

Completed

EP Combined With RFA for Ampullary Neoplasms With Intraductal Biliary Extension

Ampullary Adenomas

China
First People's Hospital of Hangzhou

Completed

Clinical Effect and Safety of PDT and RFA for Unresectable EHCC

Cholangiocarcinoma

China
First People's Hospital of Hangzhou

Completed

Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma

Cholangiocarcinoma

China
First People's Hospital of Hangzhou

Completed

Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma

Cholangiocarcinoma

China
First People's Hospital of Hangzhou

Unknown

ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC

Non-small Cell Lung Cancer Stage III | Adenocarcinoma of Lung | Non-Small-Cell Lung Cancer Metastatic | EGFR Wildtype

China
First People's Hospital of Hangzhou

Unknown

A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy

Lung Adenocarcinoma | EGFR Positive Non-small Cell Lung Cancer
First People's Hospital of Hangzhou

Completed

Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis

Cholangitis | Complication

China
First People's Hospital of Hangzhou

Unknown

Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung | Carcinoma, Squamous Cell

China
First People's Hospital of Hangzhou

Not yet recruiting

Clinical Research on the Application of Single-channel Uterine Fibroid Morcellation System in Laparoscopic Myomectomy

Leiomyoma, Uterine

China
First People's Hospital of Hangzhou

Recruiting

Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma

Bile Duct Cancer | Extrahepatic Cholangiocarcinoma

China
First People's Hospital of Hangzhou

Not yet recruiting

Biomarkers of Stage III Locally Advanced Unresectable Non-small-cell Lung Cancer

Non-small Cell Lung Cancer Stage III

China
First People's Hospital of Hangzhou

Completed

Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation

Liver Transplantation | Hepatocellular Carcinoma | Prognosis
First People's Hospital of Hangzhou

Completed

Distinct Alterations in Gut Microbiota Composition Among Women of Reproductive Age With Elevated Homocysteine Levels.

Recurrent Miscarriage

China
First People's Hospital of Hangzhou

Enrolling by invitation

Spyglass-guided Lithotripsy Versus ESWL for Pancreatic Duct Stones

Pancreatic Duct Stone

China
First People's Hospital of Hangzhou

Completed

EUS-guided Biliary Drainage vs. ERCP Assisted Transpapillary Drainage for Malignant Biliary Obstruction

Malignant Biliary Obstruction

China
First People's Hospital of Hangzhou

Completed

A Comparison Between Lumen-apposing Metal Stent and Double-pigtail Plastic Stents for Treatment of Walled-off Necrosis

Walled-off Necrosis

China
First People's Hospital of Hangzhou

Completed

EUS-RFA for Unresectable Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma

China
First People's Hospital of Hangzhou

Completed

EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma

Pancreatic Adenocarcinoma Non-resectable

China
First People's Hospital of Hangzhou

Unknown

Application of Ultrasonic Gray-scale Ratio in Differentiating Benign From Malignant Thyroid Nodules.

Thyroid Nodule

China
First People's Hospital of Hangzhou

Completed

T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI Failure

Non-small Cell Lung Cancer Stage III | Non-Small-Cell Lung Cancer Metastatic

China
First People's Hospital of Hangzhou

Completed

EGFR Mutations on ctDNA in Patients With Advanced NSCLC

Non-small Cell Lung Cancer Stage III | Non-Small-Cell Lung Cancer Metastatic

China
First People's Hospital of Hangzhou

Unknown

A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer

Squamous Cell Lung Cancer

China
First People's Hospital of Hangzhou
Hangzhou Cancer Hospital

Recruiting

SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC

Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC

China
First People's Hospital of Hangzhou

Recruiting

Endoscopic Scissors Cutting Nasobiliary Duct VS Bilateral Plastic Stent

Bile Duct Diseases | Hilar Cholangiocarcinoma | Klatskin Tumor | Biliary Disease | Biliary Stricture | Bile Duct Stenosis | Cholangiocarcinoma, Hilar

China
First People's Hospital of Hangzhou

Recruiting

Safety Study of Fenofibrate During Pregnancy

Severe Hypertriglyceridemia During Pregnancy

China
First People's Hospital of Hangzhou

Recruiting

A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection (VATH-1)

Helicobacter Pylori Infection | Proton Pump Inhibitor | Vonoprazan

China
First People's Hospital of Hangzhou

Not yet recruiting

A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases

Brain Metastases | EGFR Positive Non-small Cell Lung Cancer

China
First People's Hospital of Hangzhou

Recruiting

Dual-scopic Pancreatic Necrosectomy (DPN)

Pancreatic Diseases | Pancreatitis | Pancreatitis, Acute Necrotizing

China
First People's Hospital of Hangzhou

Enrolling by invitation

Clinical Study on "Pain Control of Cervical Dilation by Lidocaine Solution Injected Into a Disposable Cervical Dilator"

Cervical Dilatations

China
First People's Hospital of Hangzhou

Enrolling by invitation

Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma

Malignant Biliary Obstruction | Extrahepatic Cholangiocarcinoma

China
First People's Hospital of Hangzhou

Active, not recruiting

Corneal Flap Transplantation for Macular Hole Repair of High Myopia

Retinal Perforations | Myopia, Degenerative

China
First People's Hospital of Hangzhou

Completed

The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis

Post-ERCP Pancreatitis | Pancreatitis, Acute Necrotizing

China
First People's Hospital of Hangzhou

Completed

Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of Choledocholithiasis

Recurrence | Choledocholithiasis

China
First People's Hospital of Hangzhou

Completed

RCT on Necessity of Cholecystectomy for Patients After Clearance of Bile Duct Stones

Complication | Cholecystectomy | Gallbladder Stones

China
First People's Hospital of Hangzhou

Unknown

Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy

Lung Adenocarcinoma

China
First People's Hospital of Hangzhou

Unknown

Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer

Esophageal Cancer

China
The Third People's Hospital of Hangzhou

Completed

Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation

Inflammation | Dermatomyositis | Myocardial Repolarization

China
First People's Hospital of Hangzhou
Cttq

Unknown

Anlotinib Therapy in Patients With Advanced Lung Cancer.

Lung Neoplasms

China
First People's Hospital of Hangzhou
Hangzhou Cancer Hospital; First People's Hospital of Lin'an District; First People...

Recruiting

Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients

Hospitalized Patients

China
People's Hospital of Zhengzhou University

Completed

An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM

Invasive Fungal Infection

China
People's Hospital of Zhengzhou University

Completed

PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy

T2DM (Type 2 Diabetes Mellitus)

Clinical Trials Sponsored by Seventh People's Hospital of Hangzhou

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations